S100A8 and Bartsocas-Papas syndrome 1: Collectively, these findings propose that the three identified candidate genes—PLAC8, S100A8, and PPBP—may play crucial roles in the disease progression of IC/BPS patients, serving as potential diagnostic markers and therapeutic targets.